XTL completes private placement

Autoimmune company XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB; Tel Aviv:XTL) raised $2.8 million through the sale of 1.4 million ADSs at $2 in a private placement to existing investors on March 7. Inve...